The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double‐blind clinical trial

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The beneficial effects of pomegranate have been shown on insulin resistance and obesity, which are linked to NAFLD pathogenesis. The aim of this study was to investigate the efficacy of pomegranate extract in patients with NAFLD. Forty‐four NAFLD patients were randomly assigned to receive two pomegranate extract tablets or placebo for 12 weeks. Anthropometric measurements, serum lipids, glycemic indicators, and blood pressure were assessed at baseline and the end of the study. Pomegranate was associated with a reduction in the total cholesterol (p ˂ .001), triglyceride (p ˂ .001), low‐density lipoprotein cholesterol (LDL‐C)‐to‐high‐density lipoprotein cholesterol (HDL‐C) ratio (p ˂ .003), fasting blood sugar (p ˂ .001), homeostatic model assessment of insulin resistance (p = .02), diastolic blood pressure (p = .04), weight (p ˂ .001), body mass index (p ˂ .001), and waist circumference (p = .002), as compared to placebo. A significant increase was observed in serum HDL‐C (p ˂ .001) after intervention with the pomegranate extract. However, no significant difference was shown between the two groups in serum insulin and LDL‐C. The pomegranate extract supplement could be used as a complementary therapy along with existing therapies to improve glycemic indicators, serum lipids, anthropometric indices, and blood pressure in patients with nonalcoholic fatty liver.

• Publication year

  2021

• Venue

  Phytotherapy Research

• Publication date

  2021-09-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ptr.7249PMID 34498307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pomegranate variety and pomegranate plant part, relevance from bioactive point of view: a review

  2021cited by this paper
• The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial

  2020cited by this paper
• Serum 25-hydroxyvitamin D is associated with insulin resistance independently of obesity in children ages 5-17.

  2020cited by this paper
• Pomegranate juice as a functional food: a comprehensive review of its polyphenols, therapeutic merits, and recent patents.

  2020cited by this paper
• Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

  2019cited by this paper
• Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta‐analysis of randomized controlled trials

  2019cited by this paper
• A review on proactive pomegranate one of the healthiest foods

  2019cited by this paper
• Effects of pomegranate aril juice and its punicalagin on some key regulators of insulin resistance and oxidative liver injury in streptozotocin-nicotinamide type 2 diabetic rats

  2019cited by this paper
• Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future

  2018cited by this paper
• The Endotoxemia Marker Lipopolysaccharide‐Binding Protein is Reduced in Overweight‐Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial

  2018cited by this paper
• Effects of pomegranate juice on blood pressure: A systematic review and meta‐analysis of randomized controlled trials

  2017cited by this paper
• Pomegranate as a Possible Treatment in Reducing Risk of Developing Wound Healing, Obesity, Neurodegenerative Disorders, and Diabetes Mellitus.

  2017cited by this paper
• Effect of pomegranate extract on blood pressure and anthropometry in adults: a double-blind placebo-controlled randomised clinical trial

  2017influential reference
• Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients

  2017cited by this paper
• Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

  2017cited by this paper
• Interaction between plasma fetuin‐A and free fatty acids predicts changes in insulin sensitivity in response to long‐term exercise

  2017cited by this paper
• Effects of Dietary Pomegranate Extract and Inulin in Mice Fed an Obesogenic Diet

  2017influential reference
• Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation.

  2017cited by this paper
• Effects of Pomegranate and Orange Juice on Antioxidant Status in Non-Alcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial.

  2016cited by this paper
• Pomegranate extract and exercise provide additive benefits on improvement of immune function by inhibiting inflammation and oxidative stress in high-fat-diet-induced obesity in rats.

  2016cited by this paper
• Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials

  2016cited by this paper
• Pomegranate extract decreases oxidative stress and alleviates mitochondrial impairment by activating AMPK-Nrf2 in hypothalamic paraventricular nucleus of spontaneously hypertensive rats

  2016cited by this paper
• Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran

  2016cited by this paper
• The metabolic flux regulation of Klebsiella pneumoniae based on quorum sensing system

  2016cited by this paper
• Hepatokines and non-alcoholic fatty liver disease.

  2016cited by this paper
• Hepatokines and non-alcoholic fatty liver disease

  2016cited by this paper
• Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms.

  2016cited by this paper
• Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial.

  2016influential reference
• PPAR‐α agonist elicits metabolically active brown adipocytes and weight loss in diet‐induced obese mice

  2015cited by this paper
• Effect of Pomegranate Extract Consumption on Cardiovascular Disease RiskFactors, Stress Hormones, and Quality of Life in Human Volunteers: An Exploratory Randomised, Double-Blind, Placebo-Controlled Trial

  2015influential reference
• Clinical Evaluation of Blood Pressure Lowering, Endothelial Function Improving, Hypolipidemic and Anti‐Inflammatory Effects of Pomegranate Juice in Hypertensive Subjects

  2014cited by this paper
• Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

  2014cited by this paper
• Fresh pomegranate juice ameliorates insulin resistance, enhances β-cell function, and decreases fasting serum glucose in type 2 diabetic patients.

  2014cited by this paper
• Mitochondrial Dysfunction in Obesity-Associated Nonalcoholic Fatty Liver Disease: The Protective Effects of Pomegranate with Its Active Component Punicalagin

  2014cited by this paper
• Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.

  2013cited by this paper
• Pomegranate and type 2 diabetes.

  2013cited by this paper
• Effects of pomegranate juice on insulin and glucose in diabetic and non-diabetic male rats

  2013cited by this paper
• Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study

  2013cited by this paper
• Obesity: the preventive role of the pomegranate (Punica granatum).

  2012cited by this paper
• Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes.

  2012cited by this paper
• Intake of polyphenol-rich pomegranate pure juice influences urinary glucocorticoids, blood pressure and homeostasis model assessment of insulin resistance in human volunteers

  2012influential reference
• Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota

  2012cited by this paper
• The effects of pomegranate juice consumption on blood pressure and cardiovascular health.

  2011cited by this paper
• Pomegranate as a functional food and nutraceutical source.

  2011cited by this paper
• Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease

  2011cited by this paper
• Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health

  2011cited by this paper
• Effect of pomegranate juice on Angiotensin II‐induced hypertension in diabetic wistar rats

  2010cited by this paper
• Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

  2010cited by this paper
• Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut Microbiota

  2009cited by this paper
• Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size.

  2008cited by this paper
• Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice

  2007influential reference
• Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia.

  2006cited by this paper
• Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

  2005cited by this paper
• Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

  2003cited by this paper
• Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator

  2002cited by this paper
• Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator.

  2002cited by this paper
• WY14,643, a Peroxisome Proliferator-activated Receptor α (PPARα) Agonist, Improves Hepatic and Muscle Steatosis and Reverses Insulin Resistance in Lipoatrophic A-ZIP/F-1 Mice*

  2002cited by this paper
• WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.

  2002cited by this paper
• Food Composition Table

  1987influential reference

• The application of Punica granatum L. in traditional medicine and advances in modern pharmacological activity research

  2026cites this paper
• Nutritional and Pharmacological Significance of Pomegranate (Punica granatum L): A Comprehensive Narrative Review.

  2025cites this paper
• The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis.

  2025cites this paper
• Impacts of supplementation with pomegranate on cardiometabolic risk factors: A systematic review and dose-response meta-analysis.

  2025cites this paper
• Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis

  2025cites this paper
• An Updated Systematic Review and Meta-Analysis of Pomegranate Consumption on Lipid Profile.

  2025cites this paper
• The effect of pomegranate products on glycemic profile in adults: a GRADE- assessed systematic review and dose-response meta-analysis of randomized controlled trials

  2025cites this paper
• The effects of pomegranate consumption on glycemic indices in adults: A systematic review and meta-analysis.

  2024cites this paper
• Anthocyanin: A Potential Phytochemical Candidate for the Amelioration of Non-Alcoholic Fatty Liver Disease.

  2024cites this paper
• The effects of pomegranate consumption on blood pressure in adults: A systematic review and meta‐analysis

  2024influential citation
• Effects of Ellagic Acid on Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis

  2024cites this paper
• The effects of pomegranate (Punica granatum) on nonalcoholic fatty liver disease: A systematic review of in vivo interventional studies

  2024influential citation
• Nutraceutical and Dietary Measures with Potential for Preventing/Controlling Non-Alcoholic Fatty Liver Disease and Its Complications

  2024cites this paper
• Lack of Efficacy of Pomegranate Supplementation on Insulin Resistance and Sensitivity: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

  2024cites this paper
• The Effect of 12 Weeks of Combined Training on the Serum Levels of Liver Enzymes in Men with Non-Alcoholic Fatty Liver Disease

  2024cites this paper
• Crosstalk between dietary pomegranate and gut microbiota: evidence of health benefits

  2023influential citation
• Bioactive compounds and health benefits of pomegranate: An updated narrative review

  2023cites this paper
• What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)

  2023cites this paper
• Therapeutic Potential of Herbal medicine against Non-alcoholic Fatty Liver Disease.

  2023cites this paper
• Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial

  2023cites this paper
• A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation

  2023cites this paper
• The effects of pomegranate consumption on obesity indices in adults: A systematic review and meta‐analysis

  2023influential citation
• The effects of pomegranate consumption on liver function enzymes in adults: A systematic review and meta-analysis.

  2023cites this paper
• Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds

  2023cites this paper
• The effects of pomegranate consumption on lipid profile in adults: A systematic review and meta-analysis

  2023cites this paper
• Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial.

  2022cites this paper
• Evaluation of a Dietary Supplementation Combining Protein and a Pomegranate Extract in Older People: A Safety Study

  2022cites this paper
• Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review.

  2022cites this paper
• Sinapine improves LPS-induced oxidative stress in hepatocytes by down-regulating MCJ protein expression.

  2022cites this paper